Clinical trials
Cognitive Dysfunction trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 8 |
| Unknown status | 5 |
| Terminated | 3 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masaryk University | 8 |
| Charles University, Czech Republic | 3 |
| University Hospital Hradec Kralove | 3 |
| National Institute of Mental Health, Czech Republic | 2 |
| Tomas Bata Hospital, Czech Republic | 2 |
| Bristol-Myers Squibb | 1 |
| CIATRIX, INC. | 1 |
| Ecole Polytechnique Fédérale de Lausanne | 1 |
| Eisai Co., Ltd. | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 35 |
| Alzheimer Disease | 11 |
| Dementia | 7 |
| Schizophrenia | 4 |
| Memory Disorders | 3 |
| Neurodegenerative Diseases | 2 |
| Postoperative Cognitive Complications | 2 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cognition Disorders | 1 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.